Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy in advanced urinary bladder cancer.

F Edsmyr, L Andersson, P L Esposti

    Urology
    |March 1, 1984
    PubMed
    Summary

    The combination of cisplatinum (CDDP) and doxorubicin shows promise for treating recurrent urinary bladder cancer, including local tumors and metastases. This chemotherapy regimen offers a new approach for advanced cases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The corn inhibitor of activated Hageman factor: purification and properties of two recombinant forms of the protein.

    Protein expression and purification·1998
    Same author

    Mapping quantitative trait loci for immune capacity in the pig.

    Journal of immunology (Baltimore, Md. : 1950)·1998
    Same author

    Type of treatment and estimation of time spent on dental trauma--a longitudinal and retrospective study.

    Swedish dental journal·1998
    Same author

    Distress level in men undergoing intracytoplasmic sperm injection versus in-vitro fertilization.

    Human reproduction (Oxford, England)·1998
    Same author

    Genomic approaches to the improvement of disease resistance in farm animals.

    Revue scientifique et technique (International Office of Epizootics)·1998
    Same author

    Xenoduplex analysis--a method for comparative gene mapping using hybrid panels.

    Genome research·1998

    Area of Science:

    • Oncology
    • Urology
    • Medical Chemistry

    Background:

    • Recurrent urinary bladder cancer presents significant treatment challenges.
    • Current treatments like surgery and radiotherapy offer limited efficacy for advanced or metastatic disease.
    • Chemotherapy protocols are continuously being evaluated for improved patient outcomes.

    Purpose of the Study:

    • To evaluate the efficacy of different chemotherapy protocols for recurrent urinary bladder cancer.
    • To identify the most effective chemotherapeutic agents for local tumor control and metastasis management.
    • To explore novel therapeutic strategies, including neoadjuvant combination chemotherapy.

    Main Methods:

    • Retrospective analysis of chemotherapy protocols in patients with recurrent urinary bladder cancer.
    • Evaluation of treatment response for local tumors and distant metastases.
    • Assessment of patient tolerance and treatment completion rates for various regimens.

    Main Results:

    • Combination chemotherapy with cisplatinum (CDDP) and doxorubicin demonstrated superior results in recent years.
    • This combination proved effective against both local bladder tumors and metastatic disease.
    • Neoadjuvant combination therapy with CDDP and doxorubicin is under investigation as a novel approach.

    Conclusions:

    • CDDP and doxorubicin combination therapy is a highly effective treatment for recurrent urinary bladder cancer.
    • This regimen offers a viable option for managing both local and metastatic disease.
    • Further investigation into neoadjuvant application of this combination is warranted, with attention to patient tolerability.

    Related Experiment Videos